Harmful impact of EU clinical trials directive: trial of alerting drug in fibromyalgia has had to be abandoned.
BMJ
.
2006 Mar 18;332(7542):666.
doi: 10.1136/bmj.332.7542.666.
Authors
Christopher D Hanning
,
Patricia Rentowl
PMID:
16543347
PMCID:
PMC1403272
DOI:
10.1136/bmj.332.7542.666
No abstract available
Publication types
Comment
Letter
MeSH terms
Clinical Trials as Topic / legislation & jurisprudence*
European Union
Fibromyalgia / drug therapy*
Guidelines as Topic
Humans